scanX
Home
Mangalam Drugs & Organics

Mangalam Drugs & Organics

126.85
-0.52
(-0.41%)
Market Cap (₹ Cr.)
₹201
52 Week High
144.99
Book Value
₹
52 Week Low
90.80
PE Ratio
PB Ratio
1.48
PE for Sector
38.62
PB for Sector
4.62
ROE
0.84 %
ROCE
1.82 %
Dividend Yield
0.00 %
EPS
₹0.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-1.07 %
Net Income Growth
-812.51 %
Cash Flow Change
-68.04 %
ROE
-860.60 %
ROCE
-81.47 %
EBITDA Margin (Avg.)
-32.41 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
76
70
73
82
70
67
76
81
83
55
83
75
67
59
72
49
48
65
67
63
89
104
98
90
93
105
123
102
121
110
108
63
91
87
82
97
102
77
Expenses
70
63
65
73
56
58
66
69
69
45
68
61
58
54
66
50
48
60
61
57
81
90
79
76
81
94
109
88
111
99
100
57
91
91
79
90
91
68
EBITDA
6
7
8
9
14
9
11
12
14
10
15
13
10
5
6
-1
0
5
6
6
8
14
18
14
12
11
14
14
10
10
8
7
1
-3
2
7
12
8
Operating Profit %
13 %
9 %
11 %
11 %
20 %
14 %
14 %
15 %
17 %
18 %
18 %
17 %
14 %
8 %
8 %
-2 %
1 %
8 %
9 %
8 %
8 %
13 %
18 %
14 %
10 %
10 %
4 %
14 %
8 %
8 %
6 %
10 %
-1 %
-5 %
2 %
7 %
11 %
11 %
Depreciation
1
1
1
1
1
1
1
1
2
1
1
1
3
2
2
2
2
2
2
2
2
2
2
2
3
2
3
3
3
3
3
3
3
3
4
4
4
4
Interest
2
2
2
2
3
2
2
2
3
3
3
3
3
2
2
2
3
3
3
3
2
2
3
2
2
3
3
3
3
4
3
3
3
3
3
3
4
4
Profit Before Tax
3
4
5
6
10
6
7
8
9
6
10
9
4
1
2
-5
-4
1
1
1
3
10
13
9
7
6
8
9
5
4
3
1
-6
-10
-5
0
4
1
Tax
-1
1
1
2
4
2
2
2
3
2
4
3
1
0
0
-1
0
0
0
-1
0
2
2
3
2
2
2
4
1
1
1
-0
-2
0
0
-0
0
0
Net Profit
3
3
4
4
6
5
5
6
7
4
7
6
3
1
2
-4
-6
1
1
2
5
8
11
6
2
4
5
4
7
3
2
0
-4
-10
-4
1
4
3
EPS in ₹
2.65
2.32
2.77
2.64
3.85
2.88
3.25
3.85
4.11
2.63
4.23
3.78
1.93
0.42
1.09
-2.79
-3.80
0.47
0.51
1.04
3.19
5.24
7.00
4.07
1.36
2.79
2.86
2.54
4.23
1.92
1.41
0.27
-2.77
-6.02
-2.25
0.32
2.24
1.70
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
170
160
190
227
211
231
264
328
358
357
Fixed Assets
53
54
93
102
103
101
118
135
142
147
Current Assets
116
100
96
123
105
119
134
185
203
200
Capital Work in Progress
0
5
0
0
0
1
6
6
9
8
Investments
0
0
2
0
0
0
0
0
0
0
Other Assets
117
100
95
125
107
128
140
188
206
202
Total Liabilities
141
98
104
123
116
127
133
178
206
215
Current Liabilities
99
73
78
100
91
109
109
130
164
181
Non Current Liabilities
41
25
26
23
25
17
24
48
42
34
Total Equity
29
62
86
104
96
104
131
151
152
142
Reserve & Surplus
16
47
70
88
80
88
115
135
136
127
Share Capital
13
14
16
16
16
16
16
16
16
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-0
0
-0
1
0
-1
1
-1
-0
Investing Activities
-4
-11
-39
-16
-9
-7
-31
-27
-22
-18
Operating Activities
14
22
43
25
22
31
28
26
38
12
Financing Activities
-10
-11
-3
-9
-11
-23
3
3
-17
6
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
50.53 %
50.53 %
50.53 %
50.53 %
50.53 %
50.42 %
50.42 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
50.32 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.10 %
0.10 %
0.10 %
0.10 %
0.10 %
0.10 %
0.10 %
0.10 %
0.26 %
0.21 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
49.46 %
49.46 %
49.46 %
49.46 %
49.36 %
49.47 %
49.48 %
49.58 %
49.58 %
49.58 %
49.58 %
49.58 %
49.42 %
49.47 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,868.10 4,46,864.13 42.38 49,887.17 12.06 9,648 42.62 67.27
Cipla
1,637.55 1,33,866.34 30.12 26,520.66 14.17 4,155 17.77 53.84
Dr Reddys Laboratories
6,650.35 1,10,964.30 19.94 28,905.40 12.36 5,578 -0.90 45.69
Mankind Pharma
2,734.30 1,06,222.78 54.13 10,615.63 19.57 1,942 9.89 74.75
Zydus Life Science
1,051.55 1,06,152.65 25.46 19,831.50 13.82 3,831 30.78 29.31
Lupin
2,215.75 99,523.63 43.97 20,141.50 19.94 1,936 77.69 56.52
Aurobindo Pharma
1,501.15 86,724.77 24.18 29,559.25 17.55 3,169 61.17 46.63
Alkem Laboratories
6,046.80 71,491.50 33.26 12,978.42 9.84 1,811 91.18 50.66
Glenmark Pharmaceuticals
1,697.50 48,293.68 - 12,653.09 6.58 -1,831 96.52 56.39
Biocon
375.85 44,470.22 28.49 15,621.20 35.25 1,298 478.78 55.39

Corporate Action

Technical Indicators

RSI(14)
Neutral
47.92
ATR(14)
Less Volatile
6.74
STOCH(9,6)
Neutral
32.84
STOCH RSI(14)
Oversold
4.42
MACD(12,26)
Bearish
-1.39
ADX(14)
Strong Trend
26.11
UO(9)
Bearish
33.59
ROC(12)
Downtrend But Slowing Down
-3.35
WillR(14)
Oversold
-90.70
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Fundamental Screeners
Price & Volume Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.